Press release
United States Enteral Feeding Devices Market to Reach USD 1,763.70 Million by 2034, Driven by Aging Demographics, Rising Chronic Disease Burden, and Accelerating Shift Toward Home-Based Nutritional Care
Enteral feeding devices are specialized medical tools and equipment used for the delivery of nutrients directly into the digestive tract through a feeding tube, bypassing normal oral intake. This technique is primarily used for patients experiencing difficulties in the oral intake of food products, liquids, and nutritional supplements due to various chronic illnesses, neurological conditions, or surgical recovery. Commonly used enteral feeding devices include feeding pumps, enteral feeding tubes, giving sets, enteral syringes, and consumables. These devices enable consistent and accurate delivery of nutritional formulas containing proteins, carbohydrates, fats, water, minerals, and vitamins ensuring patients receive essential nutrition even when normal eating is not possible.
United States Enteral Feeding Devices Market Overview
The United States represents one of the world's largest and most technologically advanced enteral feeding devices markets, supported by a sophisticated healthcare infrastructure, a large and rapidly aging population, and a high prevalence of chronic conditions requiring long-term nutritional intervention. The market is experiencing robust expansion driven by the country's aging demographic profile and the corresponding rise in chronic conditions including neurological disorders, gastrointestinal diseases, and oncological conditions that intensify demand for alternative nutrition delivery methods.
Key Market Figures at a Glance:
• Market Size in 2025: USD 1,048.19 Million
• Projected Market Size by 2034: USD 1,763.70 Million
• Forecast CAGR (2026-2034): 5.95%
• Dominant Product Type: Enteral Feeding Pumps (28% market share in 2025)
• Leading Age Group: Adults (82% market share in 2025)
• Largest Application Segment: Gastroenterology (33% market share in 2025)
• Dominant End User: Hospitals (64% revenue share in 2025)
• Key Segmentation: Product Type, Age Group, Application, End User, Region
These figures underscore the critical and growing role of enteral feeding devices in the U.S. healthcare ecosystem, as the convergence of demographic aging, rising chronic disease burden, and technological innovation continues to expand both the patient population requiring enteral nutritional support and the sophistication of devices available to meet their needs.
Get Insights on the United States Enteral Feeding Devices Market Access the IMARC Sample Report: https://www.imarcgroup.com/united-states-enteral-feeding-devices-market/requestsample
Key Market Drivers
1. Rapidly Aging U.S. Population and Rising Prevalence of Neurological Disorders
The United States is experiencing a significant demographic shift as its population ages, with the number of Americans aged 65 and older projected to nearly double over the coming decades. Older adults are disproportionately affected by neurological conditions such as stroke, Parkinson's disease, dementia, and multiple sclerosis all of which can severely impair swallowing function (dysphagia) and the ability to maintain adequate oral nutrition.
2. Growing Burden of Chronic Diseases Requiring Nutritional Intervention
The United States bears a heavy chronic disease burden that directly fuels demand for enteral nutritional support. Cancer patients particularly those undergoing treatment for head and neck, esophageal, and gastrointestinal cancers frequently experience severe dysphagia, mucositis, and treatment-related anorexia that necessitate enteral feeding. Patients with inflammatory bowel disease, Crohn's disease, short bowel syndrome, and other gastrointestinal disorders also frequently require enteral nutrition as a primary or adjunctive therapy.
3. Accelerating Shift Toward Home-Based Enteral Nutrition and Value-Based Care
The U.S. healthcare system's increasing emphasis on value-based care models, shorter hospital stays, and cost-efficient discharge is accelerating the transition of long-term enteral nutrition therapy from inpatient hospital settings to home care and ambulatory care environments. Home enteral nutrition (HEN) programs enable patients to receive safe and effective nutritional support in their preferred home environment, reducing hospital-associated costs and improving quality of life.
4. Technological Innovation in Smart Enteral Feeding Devices and ENFit Safety Standards
Rapid technological advancement is significantly enhancing the functionality, safety, and usability of U.S. enteral feeding devices. Modern enteral feeding pumps increasingly integrate smart technologies including built-in sensors that track feeding rates and volumes in real time, programmable settings for personalized nutrition delivery, and alarm systems that notify caregivers of potential issues such as tube occlusion or infusion completion.
5. Rising Incidence of Preterm Births and Pediatric Nutritional Support Needs
The rising incidence of preterm births in the United States is generating growing demand for specialized neonatal and pediatric enteral feeding devices. Premature infants and critically ill neonates in neonatal intensive care units (NICUs) frequently require enteral nutritional support to ensure adequate growth and development during the critical early period when oral feeding is not possible.
United States Enteral Feeding Devices Market Segmentation
By Product Type
The market is segmented into Enteral Feeding Pumps, Enteral Feeding Tubes, Giving Sets, Enteral Syringes, Consumables, and Others.
• Enteral Feeding Pumps (Dominant Segment 28% Market Share in 2025): Enteral feeding pumps command the largest product type share in the U.S. market, attributed to their superior precision in controlling feeding rates and volumes, advanced programmable features, and alarm systems that enhance patient safety across clinical and home care environments. The transition from gravity-fed systems to precision, programmable infusion technology is driving strong pump adoption. Smart enteral feeding pumps with Bluetooth connectivity, real-time monitoring capabilities, and digital caregiver alert systems represent the leading innovation frontier in this segment.
• Enteral Feeding Tubes: Enteral feeding tubes including nasogastric (NG) tubes, nasojejunal (NJ) tubes, percutaneous endoscopic gastrostomy (PEG) tubes, and jejunostomy (J) tubes represent a core and high-volume product category across U.S. hospitals, long-term care facilities, and home care settings. Low-profile gastrostomy buttons are gaining increasing preference for long-term feeding in both pediatric and adult populations, offering improved patient comfort and discretion. Novel silicon-based tube variants offer superior flexibility and reduced irritation relative to older polyvinylchloride (PVC) formulations.
• Giving Sets: Giving sets the disposable tubing and administration sets connecting enteral feeding pumps to patient feeding tubes represent a high-volume, high-frequency consumable category in the U.S. market. The mandatory transition to ENFit-compliant giving sets across U.S. healthcare facilities has created a significant product upgrade cycle, driving replacement demand across both institutional and home care settings.
• Enteral Syringes: Enteral syringes are widely used for bolus feeding and medication administration through enteral feeding tubes. The transition to ENFit-compatible enteral syringes which are specifically designed to prevent connection to intravenous lines and other incompatible medical tubing is a major ongoing product conversion initiative across U.S. hospitals and home care settings, supporting sustained replacement demand in this segment.
• Consumables and Others: This segment encompasses a broad range of ancillary products including extension sets, feeding bags, skin-level devices, and accessories. The consumables segment benefits from recurring replacement demand and represents an important source of ongoing revenue for enteral feeding device manufacturers and distributors.
By Age Group
The market is segmented into Adults and Pediatrics.
• Adults (Dominant Segment 82% Market Share in 2025): The adult segment commands the overwhelming majority of the U.S. enteral feeding devices market, driven by the heavy burden of age-related neurological conditions (stroke, Parkinson's disease, dementia), oncological conditions, and gastrointestinal disorders that impair oral food intake among the aging American population. Adults receiving long-term enteral nutrition primarily via PEG tubes represent a large and growing patient population in U.S. skilled nursing facilities, rehabilitation centers, and home care settings.
• Pediatrics: The pediatric segment, while smaller in current market share, is one of the fastest-growing segments in the U.S. enteral feeding devices market. Growth is driven by rising preterm birth rates, increasing survival of neonates with complex congenital conditions, and expanding clinical recognition of pediatric feeding disorders and neurodevelopmental conditions requiring enteral nutritional support. Advances in neonatal intensive care are continuously expanding the population of pediatric patients who require specialized enteral feeding solutions.
By Application
Key application segments include:
• Gastroenterology (Dominant Segment 33% Market Share in 2025): Gastroenterology represents the largest application segment in the U.S. enteral feeding devices market, reflecting the high prevalence of gastrointestinal disorders requiring nutritional support in the American patient population. Conditions including Crohn's disease, ulcerative colitis, short bowel syndrome, gastroparesis, and post-surgical gastrointestinal recovery drive strong demand for enteral feeding solutions in gastroenterology practices and gastroenterology units across U.S. hospitals.
• Oncology: Cancer patients represent a major and growing user population for U.S. enteral feeding devices. Head and neck cancer treatments, esophageal cancer, and gastrointestinal malignancies frequently cause severe dysphagia, mucositis, and treatment-related anorexia that necessitate enteral feeding. The growing U.S. cancer incidence and expanding use of aggressive multimodal cancer treatment regimens are sustaining strong enteral feeding device demand in oncology settings.
• Neurology: Neurological conditions including stroke, amyotrophic lateral sclerosis (ALS), multiple sclerosis, Parkinson's disease, and traumatic brain injury are leading causes of dysphagia and oral feeding incapacity in the United States. Patients with neurological conditions often require long-term enteral nutritional support, making neurology a critical and structurally growing end-user application segment for enteral feeding devices across hospitals, rehabilitation facilities, and home care settings.
• Diabetes: Diabetic patients with gastroparesis a condition that slows or stops the movement of food from the stomach to the small intestine frequently require enteral feeding to maintain adequate nutrition. The high and growing prevalence of diabetes and diabetic complications in the United States is driving steady demand for enteral feeding devices in endocrinology and gastroenterology practices.
• Hypermetabolism and Others: Patients experiencing hypermetabolic states due to severe burns, major trauma, sepsis, or critical illness require intensive nutritional support that frequently includes enteral feeding. This application segment is primarily served by ICU and critical care settings in U.S. academic medical centers and regional trauma hospitals.
By End User
The market is segmented into Hospitals, Ambulatory Surgery Centers (ASCs), and Others (including Home Care).
• Hospitals (Dominant Segment 64% Revenue Share in 2025): Hospitals account for the largest share of U.S. enteral feeding device revenue, supported by growing awareness of hospital-associated malnutrition, increasing ICU admissions, and the necessity for comprehensive nutritional support in acute care settings. U.S. hospitals are the primary setting for enteral feeding tube placement, patient and caregiver training, and complication management. Multidisciplinary nutritional support teams in U.S. hospitals including physicians, dietitians, speech-language pathologists, and nursing staff coordinate enteral feeding protocols across a wide range of clinical departments including neurology, oncology, gastroenterology, and critical care.
• Ambulatory Surgery Centers (ASCs): The ambulatory care services segment is one of the fastest-growing end-user categories in the U.S. enteral feeding devices market, driven by the global shift toward home-based chronic care and cost-efficient discharge models. ASCs are increasingly involved in enteral access procedures such as PEG tube placement and low-profile gastrostomy button insertion, as advances in minimally invasive endoscopic techniques enable these procedures to be safely performed in outpatient settings.
• Others (Home Care and Long-Term Care Facilities): The home care and long-term care segment encompassing home health agencies, skilled nursing facilities, and rehabilitation centers represents a rapidly growing user category for U.S. enteral feeding devices. As value-based care models incentivize shorter hospital stays and earlier discharge, more patients are transitioning to home enteral nutrition programs, driving sustained demand for portable, user-friendly, and safe enteral feeding solutions designed for non-clinical environments.
By Region
The United States enteral feeding devices market is analyzed across four key geographic regions:
• Northeast: The Northeast features a high concentration of academic medical centers, major cancer centers, and specialty neurological hospitals that are leading adopters of advanced enteral feeding technologies. The region's dense, aging urban population and sophisticated healthcare infrastructure drive strong institutional demand for premium enteral feeding solutions across both inpatient and home care settings.
• Midwest: The Midwest's large rural population and extensive network of community hospitals, rehabilitation centers, and skilled nursing facilities create strong and consistent demand for enteral feeding devices across the chronic disease and long-term care continuum. The region's significant agricultural workforce and older demographic profile contribute to a large patient population requiring enteral nutritional support.
• South: The South represents one of the largest and fastest-growing U.S. enteral feeding device markets, driven by its large and rapidly growing population, high prevalence of chronic conditions including diabetes, obesity, and cardiovascular disease that increase nutritional risk, and expanding healthcare infrastructure serving both urban centers and rural communities.
• West: The West combines major academic medical and cancer centers including leading oncology institutions in California with a large and health-conscious population. The region's progressive healthcare system, high adoption of home healthcare models, and strong technology orientation drive adoption of advanced and smart enteral feeding solutions.
Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=20554&flag=C
Emerging Trends Shaping the U.S. Enteral Feeding Devices Market in 2026-2034
• Smart and Connected Enteral Feeding Pumps: The integration of advanced smart technologies into enteral feeding pumps is transforming care management in both clinical and home settings. Next-generation pumps feature real-time feeding rate and volume monitoring sensors, programmable personalized nutrition delivery protocols, Bluetooth connectivity for remote caregiver monitoring, and automated alert systems for device issues. Wearable, ambulatory-grade smart pumps allow patients to maintain mobility during continuous enteral feeding, significantly improving quality of life for long-term enteral nutrition patients.
• Universal ENFit Connector Adoption and Safety Standardization: The ongoing industry-wide transition to ENFit standardized connectors across the U.S. enteral feeding device ecosystem represents one of the most significant safety initiatives in the market.
• Blenderized Tube Feeding and Personalized Nutritional Formulations: A notable trend reshaping the U.S. enteral nutrition landscape is the increasing preference for blenderized tube feeding formulations, where whole, minimally processed foods are blended and administered through gastrostomy tubes.
• AI-Driven Nutritional Optimization and Digital Health Integration: Artificial intelligence and machine learning are beginning to be applied to enteral feeding protocols, enabling personalized nutrition delivery optimization based on individual patient metabolic parameters, disease state, and real-time physiological monitoring data.
• Low-Profile Gastrostomy Devices and Improved Patient Comfort: Advances in low-profile gastrostomy devices including skin-level gastrostomy buttons (commonly called "G-buttons" or "Mic-Key buttons") are improving patient comfort, body image, and quality of life for long-term enteral feeding patients, particularly children.
Competitive Landscape
The United States enteral feeding devices market features a concentrated competitive landscape dominated by global medical device and healthcare companies with broad enteral nutrition portfolios. Key market participants include:
• Abbott Laboratories A global healthcare leader with a significant U.S. enteral feeding device and nutritional formula business, Abbott's medical nutrition division markets widely used enteral feeding formulas (Ensure, Jevity, Osmolite) alongside enteral delivery systems. Abbott's comprehensive portfolio spans both the enteral formula and delivery device segments, providing integrated nutritional support solutions across hospital and home care settings.
• Fresenius Kabi A leading global medical nutrition company with a strong U.S. enteral feeding device presence, Fresenius Kabi offers a comprehensive range of enteral feeding pumps, tubes, giving sets, and nutritional formulas. Its Applix enteral feeding pump with Bluetooth connectivity and smart monitoring features represents a leading smart pump solution in the U.S. market.
• Avanos Medical, Inc. A U.S.-based medical device company specializing in digestive health solutions, Avanos' MIC-KEY line of low-profile gastrostomy feeding buttons is one of the most widely used gastrostomy access devices in the U.S. pediatric and adult long-term enteral feeding market. The company's CORTRAK enteral access system offers electromagnetic guidance for safe feeding tube placement, reducing the need for radiographic confirmation.
• Cardinal Health, Inc. A major U.S. healthcare distributor and manufacturer with an extensive enteral feeding device portfolio, Cardinal Health distributes enteral feeding pumps, tubes, giving sets, and accessories through its broad hospital and home care supply chain network, serving a large proportion of U.S. healthcare facilities requiring enteral nutritional support products.
• Moog Inc. Moog's Medical Devices segment manufactures enteral feeding pumps and administration sets with a focus on precision delivery and patient safety. Moog's Enteralite Infinity ambulatory enteral feeding pump is widely used in U.S. home enteral nutrition programs, valued for its portability and ease of use by patients and caregivers in home care settings.
• Applied Medical Technology, Inc. (AMT) A U.S.-based specialist in enteral access devices, AMT is a leading developer and manufacturer of innovative low-profile gastrostomy devices, jejunal feeding systems, and enteral extension sets, serving both pediatric and adult enteral feeding populations across U.S. hospitals and home care settings.
ENFit connector compliance, smart pump technology capabilities, clinical evidence generation, home care product usability, and regulatory approval speed are the primary competitive differentiators in the current U.S. enteral feeding devices market.
Frequently Asked Questions (FAQs) United States Enteral Feeding Devices Market
Q1. What are enteral feeding devices and how do they work?
Enteral feeding devices are specialized medical tools used to deliver nutrients directly into the gastrointestinal tract through a feeding tube, bypassing normal oral intake. They are used for patients who are unable to consume adequate nutrition orally due to chronic illness, neurological conditions, cancer, or recovery from surgery. The delivery system typically consists of a feeding tube (nasogastric, gastrostomy, or jejunostomy), a feeding pump or gravity-based administration set, giving sets, and enteral syringes. Nutritional formulas are administered through the tube to ensure patients receive essential calories, protein, carbohydrates, fats, vitamins, and minerals.
Q2. What is the size and growth forecast of the United States enteral feeding devices market?
According to IMARC Group, the United States enteral feeding devices market size reached USD 1,048.19 Million in 2025 and is projected to reach USD 1,763.70 Million by 2034, exhibiting a CAGR of 5.95% during the forecast period 2026-2034. This robust growth is driven by the aging U.S. demographic, rising chronic disease burden, accelerating shift to home-based enteral nutrition, and ongoing technological innovation in smart enteral feeding devices.
Q3. What are the primary drivers of the United States enteral feeding devices market?
The primary market drivers include the rapidly aging U.S. population and associated surge in neurological disorders causing dysphagia, growing burden of chronic diseases (cancer, gastrointestinal disorders, diabetes) requiring nutritional intervention, accelerating shift toward home-based enteral nutrition driven by value-based care models, technological innovation in smart pumps and ENFit safety connectors, and rising incidence of preterm births creating demand for neonatal enteral feeding solutions.
Q4. Which product type dominates the U.S. enteral feeding devices market?
Enteral feeding pumps dominate the U.S. market with a 28% market share in 2025, attributed to their superior precision in controlling feeding rates and volumes, advanced programmable features, and safety alarm systems. The ongoing transition from gravity-fed systems to precision, programmable infusion technology and the increasing adoption of smart, connected pump platforms is sustaining the segment's market leadership.
Q5. Which age group accounts for the largest share of the U.S. enteral feeding devices market?
Adults account for the dominant share of the U.S. enteral feeding devices market, representing 82% of market share in 2025. This reflects the overwhelming burden of age-related neurological, oncologic, and gastrointestinal conditions that impair oral food intake among the aging U.S. population. The pediatric segment, while smaller, is one of the fastest-growing segments, driven by rising preterm birth rates and expanding neonatal intensive care capabilities.
Q6. Which application segment leads demand for enteral feeding devices in the United States?
Gastroenterology represents the largest application segment with a 33% market share in 2025, reflecting the high prevalence of gastrointestinal disorders requiring nutritional support in the U.S. patient population. Oncology is the second major application segment, driven by the large number of cancer patients requiring enteral nutritional support during aggressive treatment regimens. Neurology represents a third major application driven by the prevalence of stroke, Parkinson's disease, ALS, and other neurological conditions causing dysphagia.
Q7. Which end-user segment generates the most revenue in the U.S. enteral feeding devices market?
Hospitals account for the largest revenue share at 64% in 2025, supported by growing awareness of hospital-associated malnutrition, increasing ICU admissions, and the necessity for comprehensive nutritional support in acute care settings. However, the home care and ambulatory care segments are growing rapidly as value-based care models drive earlier hospital discharge and the transition to home enteral nutrition programs.
Author IMARC Group
IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
United States: +1-201971-6302
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Enteral Feeding Devices Market to Reach USD 1,763.70 Million by 2034, Driven by Aging Demographics, Rising Chronic Disease Burden, and Accelerating Shift Toward Home-Based Nutritional Care here
News-ID: 4490672 • Views: …
More Releases from IMARC Group
Acetic Acid Prices Fall Globally in Q1 2026; North America Sees 4.9% Surge
The global Acetic Acid Prices in 2026 is experiencing controlled volatility, primarily influenced by fluctuating feedstock costs, energy price movements, and evolving industrial demand patterns. The latest Acetic Acid price chart highlights clear regional disparities, with Asia maintaining a cost advantage due to efficient production and abundant supply, while Europe and North America face sustained pricing pressure driven by elevated energy and compliance costs.
From a commercial perspective, the Acetic Acid…
Pressure Sensitive Adhesive (PSA) Production Plant DPR & Unit Setup Report 2026
Setting up a pressure sensitive adhesive (PSA) production plant positions investors at a critical junction of the global specialty adhesives and functional coating materials supply chain one of the most versatile, cross-sector, and consistently expanding adhesive technology segments driven by the foundational role of PSA formulations in pressure-activated instant bonding applications across packaging tapes and labels, automotive interior trim and noise damping, electronics component assembly and display bonding, healthcare…
Setting Up a Biosurfactant Production Plant: DPR 2026, Step-by-Step Process & Co …
Setting up a biosurfactant production plant offers investors a strategic opportunity in the rapidly growing green chemistry and biotechnology sector, as biosurfactants-produced through microbial fermentation using bacteria, fungi, or yeast-are biodegradable, low in toxicity, and highly effective across a wide range of conditions, making them a sustainable alternative to conventional petrochemical-based surfactants; widely used in industries such as cosmetics, food processing, oil and gas, agriculture, and environmental remediation, these bio-based…
Green Ethylene Production Plant DPR - 2026: Investment Cost, Market Growth and M …
Setting up a green ethylene production plant positions investors at the leading edge of one of the fastest-growing and most strategically important segments of the global bio-based chemicals and sustainable petrochemicals industry a market primarily driven by the increasing focus on sustainable petrochemicals, stringent environmental regulations, the rising adoption of bio-based feedstocks, and the growing demand from the packaging and automotive sectors. The large and continuously expanding global base of…
More Releases for Enteral
Global Enteral Single Use Syringes Market Size, Growth, Trends & Forecast to 203 …
The enteral single-use syringes market is growing due to increasing demand for safe, hygienic, and contamination-free medical devices in hospitals, clinics, and home healthcare. These syringes are designed for precise oral or enteral medication administration, reducing the risk of cross-contamination. Rising awareness about patient safety, infection control, and disposable medical equipment is driving market growth. The adoption of single-use devices in pediatric, geriatric, and critical care settings further supports market…
Enteral Syringe Market Outlook 2025-2032: Trends, Growth Drivers Analysis| B. Br …
The latest comprehensive study on the Enteral Syringe Market industry from Coherent Market Insights delivers actionable intelligence tailored for pharmaceutical and healthcare decision-makers. Backed by robust market analysis, this research outlines the key factors shaping the industry across the U.S., U.K., Japan, Korea, and China.
🌐 Get a competitive edge with up-to-date data on market trends and innovation hotspots influencing the global landscape.
As technology and regulations evolve, the market is expected…
Enteral Syringe Market Generated Opportunities, Future Scope 2025-2032 | B. Brau …
The latest report (2025-2032) on the Enteral Syringe Market by Coherent Market Insights offers an in-depth analysis of market trends, growth factors, challenges, and competition. It explores market size, revenue, production, consumption, and CAGR, using reliable research methods for accuracy. The report also covers technological advancements, pricing trends, consumer behavior, and investment opportunities, helping businesses make smart decisions and stay competitive.
The global enteral syringe market size was valued at US$…
Enteral Nutrition Market Report 2024 - Enteral Nutrition Market Size, Innovation …
"The Business Research Company recently released a comprehensive report on the Global Enteral Nutrition Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Enteral Feeding Devices Market - Unleashing the potential of enteral feeding for …
Newark, New Castle, USA: The "Enteral Feeding Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Enteral Feeding Devices Market: https://www.growthplusreports.com/report/enteral-feeding-devices-market/8610
This latest report researches the industry structure,…
Administration of medication & enteral feeding
Introduction
An adequate way to deliver nutrients directly to the gastrointestinal tract is through enteral feeding. This definition applies to orogastric, nasogastric, and gastrostomy tube feeding in this recommendation. For a variety of causes, along with the following, a wide range of kids may need enteral feeding for a short or long time:
Not being able to consume enough nutrientsPoor swallowing or suckingStructural issues with the face or oesophagusAnorexia brought on by…
